Detalhe da pesquisa
1.
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.
Radiology
; 301(2): 295-308, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427465
2.
Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response.
Tomography
; 8(2): 891-904, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35448706
3.
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy.
Tomography
; 6(2): 101-110, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32548286
4.
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer.
Tomography
; 6(2): 216-222, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32548299
5.
Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL.
NPJ Breast Cancer
; 6(1): 63, 2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33298938
6.
X-ray luminescence computed tomography using a focused x-ray beam.
J Biomed Opt
; 22(11): 1-11, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29127693